Medication info

Echib Tablet (Ezetimibe)

Prescription medicationTabletApproval withdrawn
Ingredient · strength
Ezetimibe›10mg / 1 tablet
Manufacturer / importer
NBK Pharmaceutical Co., Ltd.
Appearance
White to almost white oblong tablet
Packaging
30 tablets (10 tablets/PTP X 3)
Approval status
Approval withdrawn

MFDS item code 202003627 · Approved 2020.05.19

This product's status changed to Approval withdrawn on 2024.07.25. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of hypercholesterolemia, mixed dyslipidemia, and homozygous sitosterolemia
Who uses it
Adults
Adult dosage
A standard cholesterol-lowering diet should be continued during treatment with this medicine. The recommended dose of this medicine is 10 mg once daily, taken with or without food. When administered concomitantly with an HMG-CoA reductase inhibitor (in patients with primary hypercholesterolemia), start this medicine at the recommended initial dose of the HMG-CoA reductase inhibitor. If the patient is already receiving a high dose of an HMG-CoA reductase inhibitor, administer this medicine concomitantly while maintaining the dose of the HMG-CoA reductase inhibitor. When this medicine is administered concomitantly with fenofibrate (in patients with mixed hyperlipidemia), administer it with fenofibrate 160mg once daily or 200mg once daily (see Precautions for Use 4. General Precautions). Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate to severe hepatic impairment (see Precautions for Use 2. Patients Who Require Caution). Administration to patients with renal impairment No dose adjustment is necessary in patients with renal impairment. Administration to elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with bile acid sequestrants Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant (see Precautions for Use 5. Interactions).

Ingredients

Manufacturer
NBK Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia, mixed dyslipidemia, and homozygous sitosterolemia

  • Primary hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • homozygous sitosterolemia
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
View approved original text

This medication is primarily used for the treatment of various forms of dyslipidemia associated with hypercholesterolemia. It is used as an adjunct to dietary measures to lower total and LDL cholesterol levels in patients with primary hypercholesterolemia, and in patients with mixed hyperlipidemia, it is administered in combination with other drugs to improve various lipid levels. Additionally, it is used in combination with existing treatment in patients with homozygous familial hypercholesterolemia when the current treatment is insufficient to enhance effectiveness. In patients with sitosterolemia, it helps lower sitosterol levels in conjunction with dietary measures. This medicine is used together with adequate dietary control and lifestyle improvements, and plays an important role in the process of excluding and managing other secondary causes. It is used to assist in the management of hyperlipidemia and associated vascular disease risk.

Dosage and Administration

Adult dosage

A standard cholesterol-lowering diet should be continued during treatment with this medicine. The recommended dose of this medicine is 10 mg once daily, taken with or without food. When administered concomitantly with an HMG-CoA reductase inhibitor (in patients with primary hypercholesterolemia), start this medicine at the recommended initial dose of the HMG-CoA reductase inhibitor. If the patient is already receiving a high dose of an HMG-CoA reductase inhibitor, administer this medicine concomitantly while maintaining the dose of the HMG-CoA reductase inhibitor. When this medicine is administered concomitantly with fenofibrate (in patients with mixed hyperlipidemia), administer it with fenofibrate 160mg once daily or 200mg once daily (see Precautions for Use 4. General Precautions). Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate to severe hepatic impairment (see Precautions for Use 2. Patients Who Require Caution). Administration to patients with renal impairment No dose adjustment is necessary in patients with renal impairment. Administration to elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with bile acid sequestrants Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant (see Precautions for Use 5. Interactions).

Precautions

This drug should not be used in patients with allergic reactions to its ingredients. Patients with active liver disease or unexplained persistently elevated liver enzyme levels should not take this drug in combination with certain lipid-lowering agents. Pregnant or breastfeeding women should be cautious as the combination of this drug with some lipid-lowering agents is prohibited. Patients with severe liver dysfunction are not recommended to use this drug, as unexpected side effects may occur if liver function is impaired. This drug is generally safe for use, but side effects such as headache, abdominal pain, diarrhea, and fatigue may occur, and if symptoms persist, consult with healthcare professionals. When using this drug in combination with other lipid-lowering agents, regular liver function tests and muscle-related tests are required, and if symptoms such as muscle pain or weakness appear, notify a physician immediately. Patients with reduced kidney function can also use this drug, but those with severe renal impairment require special caution. There may be interactions with other medications taken with this drug, so it is necessary to inform doctors or pharmacists about all medications being taken. Pregnant or lactating women must consult with healthcare professionals before taking this drug, and its use is not recommended for children under the age of 6. Elderly patients may respond sensitively to this drug, so caution is needed when taking it. In the case of overdose, visit a medical institution immediately for appropriate treatment, and this medication should be kept out of reach of children.

Side effects

  • Fatigue
  • abdominal pain
  • diarrhea
  • viral infection
  • pharyngitis
  • sinusitis
  • joint pain
  • back pain
  • cough
  • chest pain
Show 59 more
  • dizziness
  • headache
  • constipation
  • bloating
  • nausea
  • elevated AST
  • elevated ALT
  • myalgia
  • myopathy
  • rhabdomyolysis
  • elevated liver aminotransferase levels
  • hepatitis
  • thrombocytopenia
  • pancreatitis
  • sensory disturbances
  • depression
  • cholelithiasis
  • cholecystitis
  • urticaria
  • rash
  • angioedema
  • erythema multiforme
  • chest discomfort
  • edema
  • weakness
  • systemic edema
  • diabetic neuropathy
  • tremors
  • epigastric pain
  • vomiting
  • gastritis
  • dry mouth
  • discomfort in the epigastrium
  • belching
  • gastrointestinal disturbances
  • gastroesophageal reflux disease
  • tongue disorders
  • palpitations
  • congestive heart failure
  • myocardial ischemia
  • flushing
  • sputum
  • rhinorrhea
  • limb pain
  • diabetes
  • hypoglycemia
  • anemia
  • splenomegaly
  • upper respiratory infection
  • conjunctival injection
  • renal failure
  • hepatic dysfunction
  • increased serum creatinine
  • increased blood pressure
  • increased blood urea
  • increased serum creatine phosphokinase
  • abnormal liver function test
  • dyspepsia
  • nausea

Not everyone experiences these, and they can vary from person to person.

Storage

This drug is sensitive to air and moisture, so it must be stored in a tightly sealed container. Additionally, it is best to keep it at room temperature between 1 and 30 degrees Celsius, away from extreme heat or cold. Proper storage will help maintain the drug's effectiveness for a longer period.

Appearance and packaging

Appearance

White to almost white oblong tablet

Package unit

30 tablets (10 tablets/PTP X 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.